In mouse mast cells, both Fc epsilonRI and Fc gammaRIII are alpha beta gamma2 tetrameric complexes in which different alpha chains confer IgE or IgG ligand recognition while the signaling FcR beta and gamma chains are identical. We used primarily noninvasive techniques (changes in body temperature, dye extravasation) to assess systemic anaphylactic responses in nonanesthetized wild-type, Fc epsilonRI alpha chain -/-and FcR gamma chain -/-mice. We confirm that systemic anaphylaxis in mice can be mediated largely through IgG1 and Fc gammaRIII and we provide direct evidence that these responses reflect activation of Fc gammaRIII rather than Fc gammaRI. Furthermore, we show that Fc gammaRIII-dependent responses are more intense in normal than in congenic mast cell-deficient KitW/KitW-v mice, indicating that Fc gammaRIII responses have mast cell-dependent and -independent components. Finally, we demonstrate that the upregulation of cell surface expression of Fc gammaRIII seen in Fc epsilonRI alpha chain -/-mice corresponds to an increased association of Fc gammaRIII alpha chains with FcR beta and gamma chains and is associated with enhanced Fc gammaRIII-dependent mast cell degranulation and systemic anaphylactic responses. Therefore, the phenotype of the Fc epsilonRI alpha chain -/-mice suggests that expression of Fc epsilonRI and Fc gammaRIII is limited by availability of the FcR beta and gamma chains and that, in normal mice, changes in the […] 
Introduction
In the companion study (1), we showed that fatal active systemic anaphylaxis reactions to ovalbumin were expressed in normal mice, in genetically mast cell-deficient Kit W /Kit W-v mice, or in mice which lacked Fc ⑀ RI because of targeted disruption of the gene encoding the Fc ⑀ RI ␣ chain (Fc ⑀ RI ␣ chain Ϫ / Ϫ mice, reference 2), but not in mice which lacked the FcR ␥ chain (FcR ␥ chain Ϫ / Ϫ mice, reference 3) that is common to Fc ␥ RI and Fc ␥ RIII, as well as Fc ⑀ RI. We also found that Fc ⑀ RI ␣ chain Ϫ / Ϫ mice and mast cell-deficient Kit W /Kit W-v mice, but not FcR ␥ chain Ϫ / Ϫ mice, could express fatal IgG 1 -dependent passive anaphylaxis responses. Taken together with the observation that IgG 1 antibodies bind rather poorly to Fc ␥ RI (4), these findings strongly suggested that some of the cardiopulmonary changes, as well as the mortality, associated with active anaphylaxis in the mouse may be mediated by IgG 1 antibodies and Fc ␥ RIII.
However, we also found that some of the changes in heart rate (HR) 1 and/or pulmonary function which developed in association with active, or IgG 1 -dependent passive, systemic anaphylaxis were significantly greater in Fc ⑀ RI ␣ chain Ϫ / Ϫ mice than in wild-type (Fc ⑀ RI ␣ chain ϩ / ϩ ) mice. The explanation for this observation was not immediately apparent. Extensive analysis of the cell and tissue distribution of the Fc ⑀ RI ␣ chain in mice indicates that it is expressed only in mast cells and basophils (2, 5) , whereas the FcR ␥ chain common to Fc ⑀ RI and Fc ␥ RI/III is expressed in many additional cell types including macrophages, neutrophils, and natural killer cells (3, 6) . Moreover, studies in in vitro-derived mouse mast cells indicate that, in the absence of the Fc ⑀ RI ␣ chain, mast cells can exhibit increased surface expression of Fc ␥ RII and/or Fc ␥ RIII (2) .
Taken together, these findings raise the possibility that, in effector cells which ordinarily express Fc ⑀ RI (i.e., mast cells and basophils), lack of the Fc ⑀ RI ␣ chain results in increased expression of Fc ␥ RIII and increased sensitivity of these cells to IgG 1 -and Fc ␥ RIII-dependent activation. This phenomenon would be expected to increase the intensity of the pathophysiological changes associated with Fc ␥ RIII-dependent systemic anaphylaxis. On the other hand, fatal active systemic anaphylactic responses associated with cardiopulmonary changes can be elicited in mice that genetically lack mast cells (1, (7) (8) (9) (10) (11) . This finding would argue against an essential role for enhanced Fc ␥ RIII-dependent mast cell activation and mediator production as the mechanism to account for the increased intensity of active anaphylaxis in Fc ⑀ RI ␣ chain Ϫ / Ϫ versus ϩ / ϩ mice.
We pursued the studies presented here to investigate three important issues regarding the pathogenesis of anaphylaxis in mice that were not fully resolved by the companion study (1) . First, do FcR ␥ chain-dependent (and Fc ⑀ RI-independent) anaphylactic reactions reflect the activation of Fc␥RI or Fc␥RIII? Second, does the increased intensity of certain physiological changes associated with anaphylaxis in Fc␥RI ␣ chain Ϫ/Ϫ versus wild-type mice reflect increased expression of Fc␥RIII on effector cells in the absence of the Fc ⑀ RI ␣ chain? Third, to what extent are the physiological changes associated with Fc␥RIII-dependent anaphylaxis mast cell-independent?
To investigate directly the role of Fc␥RIII-dependent effector cell activation in the development of anaphylactic reactions in Fc ⑀ RI ␣ chain Ϫ/Ϫ or wild-type mice, we analyzed the responses elicited in these mice, and in genetically mast celldeficient WBB6F 1 (12) (13) (14) , upon intravenous challenge with an antibody (2.4G2, reference 15) against the external domain of Fc␥RII/III. We also determined whether the increased surface expression of Fc␥RII and/or III on mast cells which lack the Fc ⑀ RI ␣ chain reflects increased association of the common FcR ␤ and ␥ chains with mast cell Fc␥RIII in vitro. The results show that Fc␥RIII-dependent physiological responses, as well as Fc␥RIII-dependent mast cell activation, are significantly increased in Fc ⑀ RI ␣ chain Ϫ/Ϫ versus wild-type mice, but that some of the physiological changes associated with these reactions clearly can occur by mast cellindependent mechanisms. The findings also suggest that availability of the common FcR ␤ and ␥ chains may limit the surface expression, and, in turn, the function, of Fc ⑀ RI or Fc␥RIII on effector cells involved in systemic anaphylactic responses.
Methods

Animals
Fc ⑀ RI-deficient animals (Fc ⑀ RI ␣ chain Ϫ/Ϫ mice) were produced by targeted disruption of the ␣ subunit gene (2) and were then backcrossed for four generations with BALB/c mice. Heterozygous animals were then bred to obtain Fc ⑀ RI ␣ chain Ϫ/Ϫ and ϩ/ϩ (wildtype) animals with the same genetic background. Mice deficient for Fc ⑀ RI, Fc␥RI, and Fc␥RIII, because of targeted disruption of the gene for the FcR ␥ subunit (FcR ␥ chain Ϫ/Ϫ mice), have been described in detail (3). The FcR ␥ chain Ϫ/Ϫ mice used for this study were F 2 offspring of crosses between chimeras and C57BL/6 mice (3). Genetically mast cell-deficient WBB6F 1 -Kit W /Kit W-v mice, which virtually lack tissue mast cells (12) (13) (14) , and the congenic normal (WBB6F 1 -ϩ/ϩ) mice were purchased from the Jackson Biological Laboratory (Bar Harbor, ME). Unless otherwise specified, mice were of either gender and were 8-16 wk old at the beginning of the experiments. In individual experiments, mice of approximately the same age (usually, within 2-4 wk) and size were used.
The animal experiments were conducted in accordance with the Beth Israel Hospital's Institutional Animal Care and Use Committee and/or with guidelines prepared by the Committee on the Care and Use of Laboratory Animals of the Institute of Laboratory Animal Resources, National Research Council (DHHS Publication No. 86-23, revised 1985). All mice were housed in microisolator cages in facilities supplied with high efficiency particulate-free air. Selected ("sentinel") mice in each room were sampled quarterly (approximately every 3 mo) and were found to be disease-free based on microbiological, parasitological, serological, and pathological examination.
ELISA for anti-DNP IgE or IgG antibodies
96-well plates were coated overnight at 4ЊC with 2 g/ml anti-mouse IgE (PharMingen, San Diego, CA) or 10 g/ml anti-mouse IgG (Southern Biotechnology Associates, Birmingham, AL) in PBS, washed three times with PBS, and then saturated for 2 h at 37ЊC with 1% gelatin in PBS. All subsequent washes (six after each step) were performed with 0.05% (vol/vol) Tween 20 in PBS. Serial dilutions of samples and internal standards were performed in 0.1% gelatin in PBS and incubated overnight at 4ЊC. Detection of anti-DNP antibodies was performed using 125 ng/ml DNP-biotin (obtained by deactivation of DNP-biocytin succinimidyl ester) (Molecular Probes, Eugene, OR). Detection of IgE or IgG antibodies (for measurement of total IgE or IgG) was performed using a 1:2,000 dilution of goat antimouse IgG (Jackson ImmunoResearch Laboratories, Inc., West Grove, PA) or a 1:500 dilution of goat anti-mouse IgE (Binding Site, Inc., San Diego, CA). Both antibodies were conjugated to alkaline phosphatase. Revelation of DNP-biotin was performed using horseradish peroxidase-avidin and 3,3Ј,5,5Ј-tetramethylbenzidine dihydrochloride (Kirkegaard & Perry Laboratories, Inc., Gaithersburg, MD) as the chromogenic agent. Anti-DNP IgE (Sigma Chemical Co., St. Louis, MO) and anti-DNP IgG 1 (clone U 7.6) (a generous gift from Dr. R. Segal, Bethesda, MD) (16) were used as standards. The linearity range of the assays was typically 0.1-5 ng/ml for anti-DNP IgE and 1-50 ng/ml for anti-DNP IgG. Revelation of alkaline phosphataseconjugated antibodies was performed using p-nitrophenylphosphate as substrate.
Protocols
Sensitization for active systemic anaphylaxis to DNP-HSA. Mice were sensitized according to the protocol of Flores-Romo et al. (17) . Mice were injected intravenously with 300 ng of Bordetella pertussis toxin (Life Technologies, Gaithersburg, MD), then, 48 h later, they received an intraperitoneal injection of 375 or 630 g of DNP 190 -keyhole limpet hemocyanin (KLH) (prepared by incubation of 20 mg/ml KLH with 20 mg/ml 2,4-dinitrobenzene sulfonic acid, sodium salt, and 20 mg/ml K 2 CO 3 ) and 0.5% aluminium hydroxide (Rehydragel; Reheiss, Berkeley Heights, NJ) in PBS. Control animals were injected intravenously with B. pertussis toxin and then intraperitoneally with 0.5% aluminum hydroxide without DNP-KLH. Blood samples were obtained by retroorbital puncture 20 d later for determination of serum concentrations of anti-DNP IgE or IgG. 24 h later, mice were injected intravenously with 1 mg DNP 30-40 -HSA (Sigma Chemical Co.) and 2% Evan's blue dye (Aldrich Chemical Co., Milwaukee, WI) in PBS. To monitor changes in body temperature associated with anaphylaxis (18), rectal temperature was measured before antigen injection and for 40-70 min after antigen injection, using a rectal probe coupled to an analogic thermometer (Yellow Springs Instrument Co., Yellow Springs, OH), as described (2) . Animals that did not die from anaphylactic shock were killed 40-70 min after antigen challenge by cervical dislocation. For quantification of Evan's blue dye extravasation, ears were removed, minced, and incubated at 80ЊC for 3 h in 2 ml of formamide; absorbance was read at 610 nm (19) . Passive cutaneous anaphylaxis (PCA). We attempted to elicit PCA reactions, essentially as described previously (20) , by intradermal injections (with a 30-gauge needle in volumes of 20 l into the dorsal surface of the ear) of 25 ng anti-DNP IgE in PBS in the left ear, and 1.5 g anti-DNP IgG 1 in the right ear, followed 24 h later by intravenous injection of 100 g DNP-HSA in 2% Evan's blue in PBS. Control animals received the same intradermal dose of anti-Dansyl IgE (PharMingen) in the left ear and normal mouse IgG in the right ear. Quantification of Evan's blue dye extravasation was performed 30 min after injection of antigen as described above.
Physiological measurements and histologic studies
In mice, anaphylactic responses can produce a striking diminution in body temperature (2) , as well as cardiopulmonary changes. Furthermore, the temperature changes associated with systemic anaphylaxis can be monitored in mice which have been subjected to neither the general anesthesia nor the surgical manipulations that are required to prepare the mice for analysis of the cardiopulmonary changes which are associated with the response (21) . Accordingly, in this study, we primarily used changes in body temperature, as well as assessment of death rates, to investigate the intensity of the various anaphylactic responses.
In one set of experiments, we assessed the cardiopulmonary changes and mast cell degranulation associated with 2.4G2 antibodyinduced anaphylactic reactions in Fc ⑀ RI ␣ chain Ϫ/Ϫ and ϩ/ϩ mice. HR and the pulmonary mechanical parameters, dynamic compliance (C dyn ) and lung conductance (G L ), were measured (by I. Miyajima) in mice anesthetized with 70-90 mg/kg, i.p., of sodium pentobarbital using a plethysmographic method, as described in the companion study (1) . HR, C dyn , and G L were measured at multiple intervals after intravenous injection, via an indwelling jugular vein catheter, of 100 g of rat 2.4G2 antibody (or, as a control, 100 g of normal rat IgG) admixed in sterile, pyrogen-free 0.9% NaCl, in a total volume of 100 l, until death due to 2.4G2 challenge or, after a period of 60 min, cervical dislocation. Changes in HR, C dyn , and G L after injection of 2.4G2 antibody or normal rat IgG were expressed as percent change versus baseline values (1) . The state of mast cell activation was assessed (by I. Miyajima) in 1-m, Epon-embedded, Giemsa-stained sections, as described in the companion study (1, (22) (23) (24) . Mast cells were classified as "extensively degranulated" (Ͼ 50% of the cytoplasmic granules exhibiting fusion, staining alterations, and/or extrusion from the cell), "moderately degranulated" (10-50% of the granules exhibiting fusion or discharge), or "normal" (10, 20, 23, 24) .
Analysis of Fc␥RIII expression in bone marrow-derived cultured mast cells (BMCMCs)
BMCMCs were generated from Fc ⑀ RI ␣ chain Ϫ/Ϫ and ϩ/ϩ mice by culture of femoral bone marrow cells for 3 wk in the presence of IL-3 as described previously (2) . For each sample, 1.5 ϫ 10 7 cells were lysed with 1% digitonin in 150 mM NaCl and 50 mM Hepes, pH 7.4, for 30 min at 4ЊC at a concentration of 5.0 ϫ 10 7 cells/ml, then centrifuged for 20 min at 4ЊC at 14,000 rpm. The supernatants were then immunoprecipitated with either 10 g of 2.4G2 antibody or with 30 l of a rabbit antiserum specific for the cytoplasmic portion of either Fc␥RII or Fc␥RIII (a kind gift from Dr. M. Daëron, Paris, France). Samples were run on an 8-16% polyacrylamide gel and then transferred to a PVDF membrane. The section containing species with molecular masses Ͼ 21,000 D was probed with a monoclonal antibody specific for Fc ⑀ RI ␤ chain (25) , whereas the section containing species with molecular masses Ͻ 21,000 D was probed with an antiserum specific for Fc ⑀ RI ␥ chain (26) .
Statistical analysis
Differences among the various groups of mice in the time courses of body temperature, HR, C dyn , or G L responses were examined for statistical significance by ANOVA. Differences in values for Evan's blue dye extravasation into the skin, or in the maximum diminution in C dyn or G L , or the maximum HR responses, were examined by the Student's t test (two-tailed). Differences in the extent of mast cell degranulation in various groups of mice were examined for statistical significance by the 2 test. Differences in the death rates between different experimental groups were examined for statistical significance by Fisher's exact test. Differences in the serum levels of anti-DNP IgE or IgG 1 antibodies in the different experimental groups in experiments assessing active anaphylaxis were examined for statistical significance by the Mann Whitney U test. P Ͻ 0.05 was regarded as significant. Unless otherwise specified, results are expressed as the meanϮSEM.
Results and Discussion
Both Fc ⑀ RI ␣ chain Ϫ/Ϫ mice and Fc ⑀ RI ␣ chain ϩ/ϩ (wildtype) mice exhibit active anaphylaxis to challenge with DNP-HSA. We first wished to confirm, using a different antigen and assessing levels of antigen-specific IgE and IgG antibodies, the finding that active systemic anaphylaxis can be expressed in the absence of the Fc ⑀ RI ␣ chain (1). In Fig. 1 A, we show that both Fc ⑀ RI ␣ chain Ϫ/Ϫ and Fc ⑀ RI ␣ chain ϩ/ϩ (wild-type) mice developed antigen-(DNP-) specific IgE and IgG antibodies after immunization with 375 g of DNP-KLH. The serum levels of IgE anti-DNP antibodies in wild-type mice (15.4Ϯ8.7 ng/ml) were greater than those in the Fc ⑀ RI ␣ chain Ϫ/Ϫ mice (3.0Ϯ3.2 ng/ml), but this difference was not statistically significant (P Ͼ 0.05 by the Mann-Whitney U test). Fig. 1 B shows that the same groups of three Fc ⑀ RI ␣ chain Ϫ/Ϫ and three wild-type mice also developed very similar levels of increased cutaneous vascular permeability upon intravenous challenge with 1.0 mg of DNP-HSA and 2% Evan's blue dye (as assessed by quantification of the amount of Evan's blue dye extravasated into the ear skin 60 min after antigen challenge).
We also analyzed serum IgE and IgG anti-DNP antibody levels in two additional groups of three Fc ⑀ RI ␣ chain Ϫ/Ϫ mice and three wild-type mice, one group after immunization with 375 g of DNP-KLH and the other after immunization with 630 g of DNP-KLH. These DNP-KLH-immunized mice also developed antigen-specific IgE and IgG antibodies, again without statistically significant differences between the values in Fc ⑀ RI ␣ chain Ϫ/Ϫ or wild-type mice (data not shown).
All three groups of DNP-KLH-immunized or sham-immunized Fc ⑀ RI ␣ chain Ϫ/Ϫ and wild-type mice were examined for changes in body temperature in response to intravenous challenge with 1.0 mg of DNP-HSA. The results for the three groups of actively immunized or sham-immunized mice of the same genotype were very similar, and therefore are presented together in Fig. 2 . In comparison to the results obtained in antigen-challenged, nonsensitized control wild-type mice, both wild-type mice and Fc ⑀ RI ␣ chain Ϫ/Ϫ mice which had been immunized with DNP-KLH exhibited significant drops in body temperature upon antigen challenge (Fig. 2) . The drop in body temperature was more pronounced in Fc ⑀ RI ␣ chain Ϫ/Ϫ mice than in the wild-type mice, but the difference did not achieve statistical significance by ANOVA. Antigen challenge resulted in the death of six of the nine wild-type mice and seven of the nine Fc ⑀ RI ␣ chain Ϫ/Ϫ mice, versus none of the eight unsensitized wild-type mice (P Ͻ 0.01 versus the death rate in sensitized mice of either genotype by Fisher's exact test).
Fc ⑀ RI ␣ chain Ϫ/Ϫ mice exhibit a greater reduction in body temperature than wild-type mice in association with IgG 1 -dependent passive systemic anaphylaxis. The findings presented in Fig. 2 confirm, using a different antigen (DNP-KLH) and a different means of quantification (change in body temperature), the results presented in our companion study (1) , which showed that active anaphylaxis responses to ovalbumin were at least as intense in Fc ⑀ RI ␣ chain Ϫ/Ϫ mice as in the wildtype (Fc ⑀ RI ␣ chain ϩ/ϩ) mice. Clearly, the responses to antigen challenge in actively immunized wild-type mice may have reflected the contributions of both IgE and IgG 1 anti-DNP antibodies. By contrast, the available evidence strongly suggests that the responses in Fc ⑀ RI ␣ chain Ϫ/Ϫ mice had little or no IgE-dependent component. Thus, Fc ⑀ RI ␣ chain Ϫ/Ϫ mice exhibited no detectable enhancement of vascular permeability (as assessed by the extravasation of Evan's blue dye) when challenged for expression of either IgE-dependent passive cutaneous or systemic anaphylaxis (2) . Nor did they express detectable changes in HR, C dyn , or G L , significant mast cell degranulation, or death, in response to challenge for IgE-dependent systemic anaphylaxis (1). Nevertheless, we cannot formally rule out some role for IgE in the active anaphylactic responses detected in Fc ⑀ RI ␣ chain Ϫ/Ϫ mice. IgE can interact with receptors other than Fc ⑀ RI (e.g., Fc␥RII/III, reference 27) and it is possible that the patterns of expression of such receptors on various effector cells are altered as a consequence of the active immunization procedure. Therefore, we directly investigated whether IgG 1 antibodies might contribute to the drop in temperature associated with systemic anaphylactic responses in mice. We first determined whether our monoclonal IgG 1 anti-DNP antibodies could sensitize mice for the expression of PCA. As shown in Fig. 3 , the monoclonal IgG 1 anti-DNP antibodies conferred reactivity for PCA in wild-type mice or Fc ⑀ RI ␣ chain Ϫ/Ϫ mice, but not in FcR ␥ chain Ϫ/Ϫ mice. By contrast, neither Fc ⑀ RI ␣ chain Ϫ/Ϫ mice nor FcR ␥ chain Ϫ/Ϫ mice expressed IgEdependent PCA responses (Fig. 3) .
We then performed dose-response experiments in normal mice to assess the ability of our monoclonal IgG 1 anti-DNP antibodies to sensitize mice for passive systemic anaphylaxis. As shown in Fig. 4 , normal mice exhibited a drop in body temperature in response to challenge with 1.0 mg of DNP-HSA that was dependent on the dose of IgG 1 anti-DNP antibodies which had been used for passive sensitization 1 d earlier. Maximal and virtually identical responses were elicited in mice which had received either 500 or 1,000 g of IgG 1 anti-DNP antibodies. We also compared the temperature responses in normal mice which had been injected with either 400 g of purified IgG 1 anti-DNP antibodies or 400 g of IgG 1 anti-DNP antibodies as a dilution of ascites, and we found that the responses were essentially identical (data not shown). In all of these experiments, none of the mice died upon antigen challenge.
We then passively sensitized Fc ⑀ RI ␣ chain Ϫ/Ϫ mice, FcR ␥ chain Ϫ/Ϫ mice, and wild-type mice with 400 g of IgG 1 anti-DNP (as a dilution of ascites) and, as a control, tested wildtype mice which had received 400 g of normal mouse IgG. Upon challenge with 1.0 mg of DNP-HSA in 2% Evan's blue, both wild-type and Fc ⑀ RI ␣ chain Ϫ/Ϫ mice developed a significant drop in body temperature compared with the response in the control, normal IgG-injected, wild-type mice (Fig. 5) . Moreover, the IgG 1 -dependent temperature reduction induced by antigen challenge in Fc ⑀ RI ␣ chain Ϫ/Ϫ mice was significantly greater (by ‫ف‬ 1.0ЊC at the maximal point of diminution, 50 min after antigen injection) than that in the identically sensitized and challenged wild-type mice (P Ͻ 0.0001 by ANOVA). By contrast, IgG 1 anti-DNP antibody-injected FcR ␥ chain Ϫ/Ϫ mice exhibited no drop in temperature upon antigen challenge (Fig. 5) .
Notably, in contrast to Fc ⑀ RI ␣ chain Ϫ/Ϫ or wild-type mice which expressed active systemic anaphylaxis, neither the Fc ⑀ RI ␣ chain Ϫ/Ϫ mice nor the wild-type mice which developed a drop in temperature in association with IgG 1 -dependent passive systemic anaphylaxis exhibited prominent cutaneous extravasation of Evan's blue dye. Indeed, by visual inspection, it was not possible to detect differences in the Evan's blue dye extravasation in the ears of these mice as opposed to those of control animals which received normal mouse IgG instead of IgG 1 anti-DNP before challenge with DNP-HSA. We did not perform actual measurements of Evan's blue dye extravasation in these experiments, however, and it is possible that our visual inspection failed to detect small differences in the dye extravasation in the ear skin of control animals versus mice treated to express IgG 1 -dependent passive systemic anaphylaxis. Nevertheless, our findings are fully consistent with results presented in the companion study (1) , which showed that the cardiopulmonary changes associated with IgG 1 -dependent passive systemic anaphylaxis can occur even in the absence of histologic evidence of substantial cutaneous mast cell degranulation.
Fc ⑀ RI ␣ chain Ϫ/Ϫ mice exhibit anaphylactic responses to challenge with 2.4G2 anti-Fc␥RII/III antibodies that are more intense than those in wild-type mice. The FcR ␥ chain is expressed in both Fc␥RI and Fc␥RIII, as well as in Fc ⑀ RI. Although IgG 1 antibodies bind more weakly to Fc␥RI than to Fc␥RIII, we wished to investigate whether anaphylactic reactions could be elicited by the direct triggering of Fc␥RIII, using an approach that does not activate Fc␥RI. Therefore, we injected mice intravenously with either 100 g of 2.4G2, a rat monoclonal antibody specific for mouse Fc␥RII/III, or, as control, the same amount of normal rat IgG. As shown in Fig. 6 , injection of 2.4G2 produced a significant drop in temperature in wild-type mice and Fc ⑀ RI ␣ chain Ϫ/Ϫ mice, but not in FcR ␥ chain Ϫ/Ϫ mice. Moreover, the temperature reduction in the Fc ⑀ RI ␣ chain Ϫ/Ϫ mice was significantly greater than that in the wild-type mice (P Ͻ 0.0003 by ANOVA).
In the companion study (1), we showed that Fc ⑀ RI ␣ chain Ϫ/Ϫ mice developed significantly more pronounced reductions in pulmonary G L and pulmonary C dyn during active systemic anaphylaxis than did the identically sensitized and challenged wild-type mice. We also found that Fc ⑀ RI ␣ chain Ϫ/Ϫ mice developed a more pronounced increase in HR, as well as a significantly greater drop in G L , in association with IgG 1 -dependent passive systemic anaphylaxis than did the identically challenged wild-type mice (1) . In light of these findings, as well as the results shown in Fig. 6 , we evaluated whether the cardiopulmonary changes associated with 2.4G2 antibody-induced anaphylaxis might be greater in Fc ⑀ RI ␣ chain Ϫ/Ϫ mice than in wild-type mice.
As shown in Fig. 7 , the reduction in G L induced by 2.4G2 challenge in Fc ⑀ RI ␣ chain Ϫ/Ϫ mice was significantly greater than that in the identically challenged wild-type mice, with maximum drops versus baseline (at 5 min after 2.4G2 injection) of 17.2Ϯ3.8% in Fc ⑀ RI ␣ chain Ϫ/Ϫ mice versus 6.8Ϯ1.8% in wild-type mice (P Ͻ 0.05 by Student's t test, twotailed). Challenge of Fc ⑀ RI ␣ chain Ϫ/Ϫ mice with 2.4G2 induced an increase in HR (to a maximum of 19.7Ϯ8.8% over baseline at 5 min after 2.4G2 injection) that was significant at the P Ͻ 0.01 level when compared with the responses in control IgG-injected Fc ⑀ RI ␣ chain Ϫ/Ϫ mice, whereas the tachycardia response in the 2.4G2-injected wild-type mice (which reached a maximum of 12.6Ϯ9.4% over baseline at 5 min after 2.4G2 injection) was significant at only the P Ͻ 0.06 level compared with the responses in control IgG-injected wild-type mice. As shown in Table I , challenge with 2.4G2 resulted in the death of all of the wild-type and Fc ⑀ RI ␣ chain Ϫ/Ϫ mice tested, whereas none of the mice injected with control IgG died. Death due to 2.4G2 injection tended to occur more rapidly in Fc ⑀ RI ␣ chain Ϫ/Ϫ mice than in wild-type mice, with death recorded at 35 min or less after 2.4G2 challenge in four of the six Fc ⑀ RI ␣ chain Ϫ/Ϫ mice versus only one of the five wild-type mice.
Notably, the kinetics of the tachycardia response to 2.4G2 injection, as well as the rapid and (in ␣ chain Ϫ/Ϫ mice) partially reversible early component of the 2.4G2-induced reduction in G L , more closely resembled the responses observed in active systemic anaphylaxis, or IgE-induced passive systemic anaphylaxis, rather than those seen in IgG 1 -induced passive systemic anaphylaxis (compare Fig. 7 to Figs. 1, 3 , and 5 in the companion study [1] ). In the companion study (1), we found that active, or IgE-induced passive, systemic anaphylactic responses were associated with more extensive mast cell degranulation than was observed in the IgG 1 -dependent passive systemic anaphylaxis responses. When tissues from the mice shown in Fig. 7 were analyzed histologically, we found that the extent of mast cell degranulation in the tissues of 2.4G2 antibody-injected Fc ⑀ RI ␣ chain Ϫ/Ϫ mice significantly exceeded that detected in the tissues of ␣ chain Ϫ/Ϫ mice which had been sensitized previously with IgG 1 anti-DNP antibodies and then challenged with DNP-HSA (compare results in Fig. 8 to those in Fig. 4 A of the companion study [1] ). Moreover, challenge with 2.4G2 antibody produced significantly greater degranulation of mast cells in the bronchial tissues and forestomach of Fc ⑀ RI ␣ chain Ϫ/Ϫ mice than in the corresponding tissues of wild-type mice (P Ͻ 0.001 for either comparison) (Fig. 8) .
Taken together, these findings suggest that, under the conditions of our experiments, the cross-linking of Fc␥RIII by 2.4G2 may represent a stronger trigger for the production of bioactive mediators by effector cells than activation of the cells via IgG 1 anti-DNP-DNP-HSA immune complexes. The results are also consistent with the possibility that mast cell activation can contribute to the intensity and/or kinetics of some of the pathophysiological changes associated with systemic anaphylactic responses, even though mast cells clearly are not required for the expression of the reactions. The more rapid development of physiological changes in 2.4G2 antibodydependent, versus IgG 1 -and antigen-dependent, responses may reflect the difference in the mechanisms of Fc␥RIII crosslinking in these two models: 2.4G2 antibodies directly induce receptor cross-linking, whereas IgG 1 must first form immune complexes with antigen and then bind to, and induce crosslinking of, Fc␥RIII. (Fig. 9 A) . None of the mice in this experiment died as a result of IgG 1 -or IgE-dependent passive systemic anaphylaxis. These findings indicate that while mast cells may have been essential for the development of IgEdependent passive anaphylaxis, mast cells made no detectable contribution to the magnitude of the drop in body temperature associated with the IgG 1 -dependent responses. This finding stands in contrast to the results obtained in our companion study, which showed that Kit W /Kit W-v mice were significantly less susceptible than the congenic ϩ/ϩ (wild-type) mice to both the cardiopulmonary changes and the mortality associated with passive systemic anaphylactic reactions that were induced by challenge with the same amounts of IgG 1 and specific antigen as used in the present study (1) .
One possible explanation for this discrepancy is that anesthetized, surgically manipulated, and artificially ventilated mice, such as those used in the companion study (1) , are more likely than nonanesthetized mice to die as a result of IgG 1 -induced systemic anaphylaxis, particularly if the responses (such as those in WBB6F 1 -ϩ/ϩ mice) are associated with mast cell degranulation. On the other hand, we found that virtually all of the Fc ⑀ RI ␣ chain Ϫ/Ϫ or ϩ/ϩ mice, or FcR ␥ chain ϩ/ϩ mice, challenged for IgG 1 -dependent passive systemic anaphylaxis in the companion study died within 1 h of antigen challenge, despite developing little or no, or only modest, levels of mast cell degranulation (1) . By contrast, in the present study, no deaths occurred in mice of the same genotypes upon challenge with amounts of IgG 1 antibody and antigen that were identical to those used in the study by Miyajima et al. (1) .
Whatever the reason(s) for the differences in the mortality associated with IgG 1 -dependent passive systemic anaphylaxis in this and the companion study (1), our analysis of Fc ⑀ RI ␣ chain Ϫ/Ϫ mice indicated that intravenous challenge with 2.4G2 antibodies produced significantly more mast cell degranulation, as well as more striking cardiopulmonary changes, than did challenge with IgG 1 and specific antigen. Therefore, we compared the responses to intravenous challenge with 2.4G2 antibodies in normal (ϩ/ϩ) and genetically mast celldeficient (Kit W /Kit W-v ) mice. We found that Kit W /Kit W-v mice exhibited a drop in body temperature in response to 2.4G2 challenge, but that the magnitude of this response was significantly less than that in the congenic normal (ϩ/ϩ) mice (P Ͻ 0.0001 by ANOVA) (Fig. 9 B) W-v mast cell-deficient mice are significantly attenuated compared with those in normal mice. By contrast, FcR ␥ chain Ϫ/Ϫ mice were unresponsive to challenge with 2.4G2 antibodies (Fig. 9 B) .
Mast cells derived from Fc ⑀ RI ␣ chain Ϫ/Ϫ mice express higher levels of Fc␥RIII than do mast cells derived from wildtype mice. One possible explanation for why challenge with 2.4G2 antibodies produced more intense physiological and mast cell degranulation responses in Fc ⑀ RI ␣ chain Ϫ/Ϫ mice than in Fc ⑀ RI ␣ chain ϩ/ϩ mice would be that mast cells in Fc ⑀ RI ␣ chain Ϫ/Ϫ mice exhibit increased expression of Fc␥RIII recent observation that the ␤ chain can increase the intensity of signal transduction via the Fc ⑀ RI (29), these findings are compatible with at least two mechanisms by which lack of the Fc ⑀ RI ␣ chain could result in increased Fc␥RIII-dependent -DNP Lysates of BMCMCs were immunoprecipitated with either a rat 2.4G2 antibody against Fc␥RII/III (2.4G2), normal rat IgG (Control), or polyclonal rat antibodies specific for the cytoplasmic domains of Fc␥RII (Anti-Fc␥RII) or Fc␥RIII (Anti-Fc␥RIII). Samples run on an 8-16% polyacrylamide gel were transferred to a PVDF membrane which then was probed separately with a monoclonal antibody specific for FcR ␤ chain (␤) and an antiserum against FcR ␥ chain (␥). compared with those in the wild-type mice. Previously, we showed that BMCMCs of Fc ⑀ RI ␣ chain Ϫ/Ϫ mouse origin exhibited increased surface expression of Fc␥RII/III (as detected by binding of 2.4G2 antibodies) compared with wild-type BMCMCs (2). However, this experiment did not discriminate between levels of expression of the two Fc␥R (Fc␥RII and Fc␥RIII) that are detected by the 2.4G2 antibody, which recognizes the highly conserved extracellular domains of Fc␥RII/ III (15) . Therefore, we generated BMCMCs of Fc ⑀ RI ␣ chain Ϫ/Ϫ mouse and wild-type (Fc ⑀ RI ␣ chain ϩ/ϩ) mouse origin, and then used antibodies specific for Fc␥RII and Fc␥RIII, as well as 2.4G2, in an attempt to immunoprecipitate FcR ␥ chains and FcR ␤ chains that might be associated with the cells' Fc␥R.
As shown in Fig. 10 , anti-Fc␥RIII or 2.4G2 antibodies, but not anti-Fc␥RII antibodies, precipitated ␤ and FcR ␥ chains from the BMCMCs. However, the amounts of ␤ or FcR ␥ chains precipitated from the Fc ⑀ RI ␣ chain Ϫ/Ϫ BMCMCs greatly exceeded those precipitated from the wild-type (ϩ/ϩ) BMCMCs. It has been reported that the FcR ␤ chain can associate with Fc␥RIII␣, as well as Fc ⑀ RI, in transfected cells (28) . Our results now show that the FcR ␤ chain can also associate with Fc␥RIII in nontransfected, bone marrow-derived mast cells. The demonstration that Fc ⑀ RI ␣ chain Ϫ/Ϫ BMCMCs express increased amounts of Fc␥RIII in comparison with wildtype BMCMCs is consistent with other lines of evidence which show that Fc␥RIII expression is increased when FcR ␥ chains and FcR ␤ chains are not incorporated into Fc ⑀ RI and therefore are available for Fc␥RIII (2, 6) . Taken together with the mast cell activation: increased expression of Fc␥RIII on the cell surface and/or increased association of the ␤ chain with Fc␥RIII.
Conclusions. In this study, we have resolved three important questions concerning the pathogenesis of systemic anaphylaxis responses in mice. First, what is the relative importance of Fc␥RI versus Fc␥RIII in FcR ␥ chain-dependent systemic anaphylactic reactions? Second, does increased surface expression of Fc␥RIII on mast cells which lack the Fc ⑀ RI ␣ chain reflect increased association of the common FcR ␤ and ␥ chains with Fc␥RIII, and does this have pathophysiological significance in vivo? Third, to what extent are the pathophysiological changes in Fc␥RIII-dependent systemic anaphylaxis mast cell-independent? To address these issues, we used measurements of body temperature to detect and quantify systemic active or passive anaphylactic reactions, or responses to injections of an antibody against Fc␥RII/III, in nonanesthetized mice which were subjected to neither surgical manipulations nor artificial ventilation.
We found that Fc ⑀ RI ␣ chain Ϫ/Ϫ mice can express active systemic anaphylactic reactions, as well as IgG 1 -dependent passive systemic anaphylaxis. We also showed that the intensity of some of the physiological changes associated with responses to IgG 1 and specific antigen or intravenous challenge with 2.4G2 anti-Fc␥RII/III antibodies was greater in Fc ⑀ RI ␣ chain Ϫ/Ϫ mice than in the wild-type animals. These observations thus confirm and extend those in our companion study, which showed that anesthetized, surgically manipulated, and artificially ventilated Fc ⑀ RI ␣ chain Ϫ/Ϫ mice challenged to express active or IgG 1 -dependent passive systemic anaphylaxis can develop changes in HR, C dyn , and G L which are at least as large as, and in some cases greater than, those in the corresponding wild-type mice (1) .
In addition, we found that the previously reported increased surface expression of Fc ⑀ RII and/or III by mouse mast cells which lack the Fc ⑀ RI ␣ chain (2) reflects the increased association of the common FcR ␤ and ␥ chains with Fc␥RIII. This finding clearly may have in vivo relevance, in that the mast cell degranulation, as well as the pathophysiological changes, associated with responses to intravenous challenge with 2.4G2 antibodies was significantly greater in Fc ⑀ RI ␣ chain Ϫ/Ϫ mice than in wild-type mice. Although these observations were made by comparing the responses in Fc ⑀ RI ␣ chain Ϫ/Ϫ mice with those in the corresponding wild-type mice, the findings strongly suggest that the expression of Fc ⑀ RI-or Fc␥RIII-dependent effector cell function in normal mice may be significantly affected by the availability of limiting amounts of the common FcR ␤ and/or ␥ chains. Thus, approaches which result in diminished expression of Fc ⑀ RI ␣ chain may result in enhanced Fc␥RIII-dependent effector function.
Finally, we observed that the responses induced by 2.4G2 antibody challenge in normal (ϩ/ϩ) mice were significantly stronger than those observed in the congenic mast cell-deficient Kit W /Kit W-v mice. In other words, although Fc␥RIII-dependent pathophysiological changes can occur in the virtual absence of mast cells, mast cells may contribute to the intensity of these reactions.
Thus, we have shown that the direct activation of Fc␥RIII with 2.4G2 antibodies, by a mechanism that does not also activate Fc␥RI, can produce physiological changes that are very similar to those observed in active anaphylaxis. This finding in normal mice, when taken together with the results obtained in Fc ⑀ RI ␣ chain Ϫ/Ϫ mice, strongly supports the hypothesis that the death associated with active systemic anaphylaxis in the mouse, as well as the drop in body temperature and other physiological changes associated with the reaction, may largely reflect IgG 1 -dependent activation of Fc␥RIII. Our findings also indicate that mast cell activation can contribute to the intensity of Fc␥RIII-dependent responses, especially in Fc ⑀ RI ␣ chain Ϫ/Ϫ mice, but that other effector cells must have important roles in the pathogenesis of these reactions. Monocytes and macrophages represent attractive candidate additional effector cells in these settings, since only these cells and natural killer cells are known to express Fc␥RIII in the mouse and since monocytes/macrophages represent potential sources of many biologically active mediators (3, 6) .
